Federation Des Caisses Desjardins Du Quebec Iovance Biotherapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $21.3 Billion
- Q2 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,250 shares of IOVA stock, worth $5,107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,250
Previous 2,250
-0.0%
Holding current value
$5,107
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IOVA
# of Institutions
287Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$65.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$48.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.8 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.5 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $358M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...